Subscribe to thousands of academic journals for just $40/month
Read and share the articles you need for your research, all in one place.

Commentary on “Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: Toxicity and outcome from a dose escalation pilot study.” T. Zilli, S. Jorcano, M. Rouzaud, G. Dipasquale, P. Nouet, J.I. Toscas, N. Casanova, H. Wang, L. Escudé, M. Mollà, D. Linero, D.C. Weber, R. Miralbell, Service de Radio-oncologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland

Details

Publisher
Elsevier
Copyright
Copyright © 2012 Elsevier Inc.
ISSN
1078-1439
D.O.I.
10.1016/j.urolonc.2012.02.014
Publisher site
See Article on Publisher Site
Expand Tray Hide Tray
Loading next page...

End of preview. The entire article is 2 pages. Rent for Free

You're using the new DeepDyve HTML5 Viewer. Having issues? Try Classic Viewer
 
/lp/elsevier/commentary-on-twice-weekly-hypofractionated-intensity-modulated-bM9Fe34x7w